An Indispensible Parameters of Trandolapril Include Indications, Pharmaco Dynamics, Actions, Route of Excretion, Half-Life Toxicity and Interactions
Year: 2025
Type: article
Abstract: Trandolapril is a non-sulfhydryl prodrug that is associated with the angiotensin-converting enzyme (ACE) inhibitor of medications. It is metabolized to its biologically active diacid form, trandolaprilat, especially in the liver. The enzyme ACE, which is necessary for the transformation of angiotensin I (ATI) into angiotensin II (ATII), is inhibited by trendolaprilat. A vital part of the renin-angiotensin-aldosterone system (RAAS), ATII regulates blood pressure. Trandolapril plays an important role regarding treatment of mild to moderate hypertension, to promote survival following myocardial infarction in stable patients in a clinical manner along with left ventricular dysfunction, as an adjunct treatment for congestive heart failure, and to reduce the rate of progression of renal disease in hypertensive individuals along with diabetes mellitus and microalbuminuria or overt nephropathy.
Authors: Moni Theresa Tsappidi, Muralinath E., Srinivas G., Guruprasad M., Ramanjaneyulu D.V.
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6893551337
FWCI:
Cites:
Cited by:
Related to: